0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Toxoplasma Antigen Test Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15I16787
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Toxoplasma Antigen Test Market Research Report 2024
BUY CHAPTERS

Global Toxoplasma Antigen Test Market Research Report 2025

Code: QYRE-Auto-15I16787
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Toxoplasma Antigen Test Market

The global market for Toxoplasma Antigen Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Toxoplasma Antigen Test is a diagnostic test used to detect the presence of antigens produced by the Toxoplasma gondii parasite in biological samples. This test is important in the diagnosis of toxoplasmosis, a parasitic infection that can affect animals and humans.
North American market for Toxoplasma Antigen Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Toxoplasma Antigen Test is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Toxoplasma Antigen Test include AVO, Rapid Labs, SERION, InTec, Testsea, Heo Technology, Arlington Scientific, AccuBio Tech, Vitrosens Biotechnology, Xiamen Boson Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Toxoplasma Antigen Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxoplasma Antigen Test.
The Toxoplasma Antigen Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Toxoplasma Antigen Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Toxoplasma Antigen Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Toxoplasma Antigen Test Market Report

Report Metric Details
Report Name Toxoplasma Antigen Test Market
Segment by Type
  • Feces
  • Blood
  • Others
Segment by Application
  • Mankind
  • Animal
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AVO, Rapid Labs, SERION, InTec, Testsea, Heo Technology, Arlington Scientific, AccuBio Tech, Vitrosens Biotechnology, Xiamen Boson Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Toxoplasma Antigen Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Toxoplasma Antigen Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Toxoplasma Antigen Test Market report?

Ans: The main players in the Toxoplasma Antigen Test Market are AVO, Rapid Labs, SERION, InTec, Testsea, Heo Technology, Arlington Scientific, AccuBio Tech, Vitrosens Biotechnology, Xiamen Boson Biotech

What are the Application segmentation covered in the Toxoplasma Antigen Test Market report?

Ans: The Applications covered in the Toxoplasma Antigen Test Market report are Mankind, Animal

What are the Type segmentation covered in the Toxoplasma Antigen Test Market report?

Ans: The Types covered in the Toxoplasma Antigen Test Market report are Feces, Blood, Others

1 Toxoplasma Antigen Test Market Overview
1.1 Product Definition
1.2 Toxoplasma Antigen Test by Type
1.2.1 Global Toxoplasma Antigen Test Market Value Comparison by Type (2024 VS 2031)
1.2.2 Feces
1.2.3 Blood
1.2.4 Others
1.3 Toxoplasma Antigen Test by Application
1.3.1 Global Toxoplasma Antigen Test Market Value by Application (2024 VS 2031)
1.3.2 Mankind
1.3.3 Animal
1.4 Global Toxoplasma Antigen Test Market Size Estimates and Forecasts
1.4.1 Global Toxoplasma Antigen Test Revenue 2020-2031
1.4.2 Global Toxoplasma Antigen Test Sales 2020-2031
1.4.3 Global Toxoplasma Antigen Test Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Toxoplasma Antigen Test Market Competition by Manufacturers
2.1 Global Toxoplasma Antigen Test Sales Market Share by Manufacturers (2020-2025)
2.2 Global Toxoplasma Antigen Test Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Toxoplasma Antigen Test Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Toxoplasma Antigen Test, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Toxoplasma Antigen Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Toxoplasma Antigen Test, Product Type & Application
2.7 Global Key Manufacturers of Toxoplasma Antigen Test, Date of Enter into This Industry
2.8 Global Toxoplasma Antigen Test Market Competitive Situation and Trends
2.8.1 Global Toxoplasma Antigen Test Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Toxoplasma Antigen Test Players Market Share by Revenue
2.8.3 Global Toxoplasma Antigen Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Toxoplasma Antigen Test Market Scenario by Region
3.1 Global Toxoplasma Antigen Test Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Toxoplasma Antigen Test Sales by Region: 2020-2031
3.2.1 Global Toxoplasma Antigen Test Sales by Region: 2020-2025
3.2.2 Global Toxoplasma Antigen Test Sales by Region: 2026-2031
3.3 Global Toxoplasma Antigen Test Revenue by Region: 2020-2031
3.3.1 Global Toxoplasma Antigen Test Revenue by Region: 2020-2025
3.3.2 Global Toxoplasma Antigen Test Revenue by Region: 2026-2031
3.4 North America Toxoplasma Antigen Test Market Facts & Figures by Country
3.4.1 North America Toxoplasma Antigen Test Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Toxoplasma Antigen Test Sales by Country (2020-2031)
3.4.3 North America Toxoplasma Antigen Test Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Toxoplasma Antigen Test Market Facts & Figures by Country
3.5.1 Europe Toxoplasma Antigen Test Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Toxoplasma Antigen Test Sales by Country (2020-2031)
3.5.3 Europe Toxoplasma Antigen Test Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Toxoplasma Antigen Test Market Facts & Figures by Region
3.6.1 Asia Pacific Toxoplasma Antigen Test Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Toxoplasma Antigen Test Sales by Region (2020-2031)
3.6.3 Asia Pacific Toxoplasma Antigen Test Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Toxoplasma Antigen Test Market Facts & Figures by Country
3.7.1 Latin America Toxoplasma Antigen Test Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Toxoplasma Antigen Test Sales by Country (2020-2031)
3.7.3 Latin America Toxoplasma Antigen Test Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Toxoplasma Antigen Test Market Facts & Figures by Country
3.8.1 Middle East and Africa Toxoplasma Antigen Test Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Toxoplasma Antigen Test Sales by Country (2020-2031)
3.8.3 Middle East and Africa Toxoplasma Antigen Test Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Toxoplasma Antigen Test Sales by Type (2020-2031)
4.1.1 Global Toxoplasma Antigen Test Sales by Type (2020-2025)
4.1.2 Global Toxoplasma Antigen Test Sales by Type (2026-2031)
4.1.3 Global Toxoplasma Antigen Test Sales Market Share by Type (2020-2031)
4.2 Global Toxoplasma Antigen Test Revenue by Type (2020-2031)
4.2.1 Global Toxoplasma Antigen Test Revenue by Type (2020-2025)
4.2.2 Global Toxoplasma Antigen Test Revenue by Type (2026-2031)
4.2.3 Global Toxoplasma Antigen Test Revenue Market Share by Type (2020-2031)
4.3 Global Toxoplasma Antigen Test Price by Type (2020-2031)
5 Segment by Application
5.1 Global Toxoplasma Antigen Test Sales by Application (2020-2031)
5.1.1 Global Toxoplasma Antigen Test Sales by Application (2020-2025)
5.1.2 Global Toxoplasma Antigen Test Sales by Application (2026-2031)
5.1.3 Global Toxoplasma Antigen Test Sales Market Share by Application (2020-2031)
5.2 Global Toxoplasma Antigen Test Revenue by Application (2020-2031)
5.2.1 Global Toxoplasma Antigen Test Revenue by Application (2020-2025)
5.2.2 Global Toxoplasma Antigen Test Revenue by Application (2026-2031)
5.2.3 Global Toxoplasma Antigen Test Revenue Market Share by Application (2020-2031)
5.3 Global Toxoplasma Antigen Test Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AVO
6.1.1 AVO Company Information
6.1.2 AVO Description and Business Overview
6.1.3 AVO Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AVO Toxoplasma Antigen Test Product Portfolio
6.1.5 AVO Recent Developments/Updates
6.2 Rapid Labs
6.2.1 Rapid Labs Company Information
6.2.2 Rapid Labs Description and Business Overview
6.2.3 Rapid Labs Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Rapid Labs Toxoplasma Antigen Test Product Portfolio
6.2.5 Rapid Labs Recent Developments/Updates
6.3 SERION
6.3.1 SERION Company Information
6.3.2 SERION Description and Business Overview
6.3.3 SERION Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SERION Toxoplasma Antigen Test Product Portfolio
6.3.5 SERION Recent Developments/Updates
6.4 InTec
6.4.1 InTec Company Information
6.4.2 InTec Description and Business Overview
6.4.3 InTec Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.4.4 InTec Toxoplasma Antigen Test Product Portfolio
6.4.5 InTec Recent Developments/Updates
6.5 Testsea
6.5.1 Testsea Company Information
6.5.2 Testsea Description and Business Overview
6.5.3 Testsea Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Testsea Toxoplasma Antigen Test Product Portfolio
6.5.5 Testsea Recent Developments/Updates
6.6 Heo Technology
6.6.1 Heo Technology Company Information
6.6.2 Heo Technology Description and Business Overview
6.6.3 Heo Technology Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Heo Technology Toxoplasma Antigen Test Product Portfolio
6.6.5 Heo Technology Recent Developments/Updates
6.7 Arlington Scientific
6.7.1 Arlington Scientific Company Information
6.7.2 Arlington Scientific Description and Business Overview
6.7.3 Arlington Scientific Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Arlington Scientific Toxoplasma Antigen Test Product Portfolio
6.7.5 Arlington Scientific Recent Developments/Updates
6.8 AccuBio Tech
6.8.1 AccuBio Tech Company Information
6.8.2 AccuBio Tech Description and Business Overview
6.8.3 AccuBio Tech Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AccuBio Tech Toxoplasma Antigen Test Product Portfolio
6.8.5 AccuBio Tech Recent Developments/Updates
6.9 Vitrosens Biotechnology
6.9.1 Vitrosens Biotechnology Company Information
6.9.2 Vitrosens Biotechnology Description and Business Overview
6.9.3 Vitrosens Biotechnology Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Vitrosens Biotechnology Toxoplasma Antigen Test Product Portfolio
6.9.5 Vitrosens Biotechnology Recent Developments/Updates
6.10 Xiamen Boson Biotech
6.10.1 Xiamen Boson Biotech Company Information
6.10.2 Xiamen Boson Biotech Description and Business Overview
6.10.3 Xiamen Boson Biotech Toxoplasma Antigen Test Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xiamen Boson Biotech Toxoplasma Antigen Test Product Portfolio
6.10.5 Xiamen Boson Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Toxoplasma Antigen Test Industry Chain Analysis
7.2 Toxoplasma Antigen Test Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Toxoplasma Antigen Test Production Mode & Process Analysis
7.4 Toxoplasma Antigen Test Sales and Marketing
7.4.1 Toxoplasma Antigen Test Sales Channels
7.4.2 Toxoplasma Antigen Test Distributors
7.5 Toxoplasma Antigen Test Customer Analysis
8 Toxoplasma Antigen Test Market Dynamics
8.1 Toxoplasma Antigen Test Industry Trends
8.2 Toxoplasma Antigen Test Market Drivers
8.3 Toxoplasma Antigen Test Market Challenges
8.4 Toxoplasma Antigen Test Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Toxoplasma Antigen Test Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Toxoplasma Antigen Test Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Toxoplasma Antigen Test Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Toxoplasma Antigen Test Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Toxoplasma Antigen Test Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Toxoplasma Antigen Test Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Toxoplasma Antigen Test Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Toxoplasma Antigen Test Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Toxoplasma Antigen Test, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Toxoplasma Antigen Test, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Toxoplasma Antigen Test, Product Type & Application
 Table 12. Global Key Manufacturers of Toxoplasma Antigen Test, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Toxoplasma Antigen Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoplasma Antigen Test as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Toxoplasma Antigen Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Toxoplasma Antigen Test Sales by Region (2020-2025) & (K Units)
 Table 18. Global Toxoplasma Antigen Test Sales Market Share by Region (2020-2025)
 Table 19. Global Toxoplasma Antigen Test Sales by Region (2026-2031) & (K Units)
 Table 20. Global Toxoplasma Antigen Test Sales Market Share by Region (2026-2031)
 Table 21. Global Toxoplasma Antigen Test Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Toxoplasma Antigen Test Revenue Market Share by Region (2020-2025)
 Table 23. Global Toxoplasma Antigen Test Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Toxoplasma Antigen Test Revenue Market Share by Region (2026-2031)
 Table 25. North America Toxoplasma Antigen Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Toxoplasma Antigen Test Sales by Country (2020-2025) & (K Units)
 Table 27. North America Toxoplasma Antigen Test Sales by Country (2026-2031) & (K Units)
 Table 28. North America Toxoplasma Antigen Test Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Toxoplasma Antigen Test Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Toxoplasma Antigen Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Toxoplasma Antigen Test Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Toxoplasma Antigen Test Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Toxoplasma Antigen Test Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Toxoplasma Antigen Test Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Toxoplasma Antigen Test Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Toxoplasma Antigen Test Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Toxoplasma Antigen Test Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Toxoplasma Antigen Test Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Toxoplasma Antigen Test Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Toxoplasma Antigen Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Toxoplasma Antigen Test Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Toxoplasma Antigen Test Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Toxoplasma Antigen Test Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Toxoplasma Antigen Test Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Toxoplasma Antigen Test Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Toxoplasma Antigen Test Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Toxoplasma Antigen Test Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Toxoplasma Antigen Test Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Toxoplasma Antigen Test Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Toxoplasma Antigen Test Sales (K Units) by Type (2020-2025)
 Table 51. Global Toxoplasma Antigen Test Sales (K Units) by Type (2026-2031)
 Table 52. Global Toxoplasma Antigen Test Sales Market Share by Type (2020-2025)
 Table 53. Global Toxoplasma Antigen Test Sales Market Share by Type (2026-2031)
 Table 54. Global Toxoplasma Antigen Test Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Toxoplasma Antigen Test Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Toxoplasma Antigen Test Revenue Market Share by Type (2020-2025)
 Table 57. Global Toxoplasma Antigen Test Revenue Market Share by Type (2026-2031)
 Table 58. Global Toxoplasma Antigen Test Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Toxoplasma Antigen Test Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Toxoplasma Antigen Test Sales (K Units) by Application (2020-2025)
 Table 61. Global Toxoplasma Antigen Test Sales (K Units) by Application (2026-2031)
 Table 62. Global Toxoplasma Antigen Test Sales Market Share by Application (2020-2025)
 Table 63. Global Toxoplasma Antigen Test Sales Market Share by Application (2026-2031)
 Table 64. Global Toxoplasma Antigen Test Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Toxoplasma Antigen Test Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Toxoplasma Antigen Test Revenue Market Share by Application (2020-2025)
 Table 67. Global Toxoplasma Antigen Test Revenue Market Share by Application (2026-2031)
 Table 68. Global Toxoplasma Antigen Test Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Toxoplasma Antigen Test Price (US$/Unit) by Application (2026-2031)
 Table 70. AVO Company Information
 Table 71. AVO Description and Business Overview
 Table 72. AVO Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AVO Toxoplasma Antigen Test Product
 Table 74. AVO Recent Developments/Updates
 Table 75. Rapid Labs Company Information
 Table 76. Rapid Labs Description and Business Overview
 Table 77. Rapid Labs Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Rapid Labs Toxoplasma Antigen Test Product
 Table 79. Rapid Labs Recent Developments/Updates
 Table 80. SERION Company Information
 Table 81. SERION Description and Business Overview
 Table 82. SERION Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. SERION Toxoplasma Antigen Test Product
 Table 84. SERION Recent Developments/Updates
 Table 85. InTec Company Information
 Table 86. InTec Description and Business Overview
 Table 87. InTec Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. InTec Toxoplasma Antigen Test Product
 Table 89. InTec Recent Developments/Updates
 Table 90. Testsea Company Information
 Table 91. Testsea Description and Business Overview
 Table 92. Testsea Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Testsea Toxoplasma Antigen Test Product
 Table 94. Testsea Recent Developments/Updates
 Table 95. Heo Technology Company Information
 Table 96. Heo Technology Description and Business Overview
 Table 97. Heo Technology Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Heo Technology Toxoplasma Antigen Test Product
 Table 99. Heo Technology Recent Developments/Updates
 Table 100. Arlington Scientific Company Information
 Table 101. Arlington Scientific Description and Business Overview
 Table 102. Arlington Scientific Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Arlington Scientific Toxoplasma Antigen Test Product
 Table 104. Arlington Scientific Recent Developments/Updates
 Table 105. AccuBio Tech Company Information
 Table 106. AccuBio Tech Description and Business Overview
 Table 107. AccuBio Tech Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AccuBio Tech Toxoplasma Antigen Test Product
 Table 109. AccuBio Tech Recent Developments/Updates
 Table 110. Vitrosens Biotechnology Company Information
 Table 111. Vitrosens Biotechnology Description and Business Overview
 Table 112. Vitrosens Biotechnology Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Vitrosens Biotechnology Toxoplasma Antigen Test Product
 Table 114. Vitrosens Biotechnology Recent Developments/Updates
 Table 115. Xiamen Boson Biotech Company Information
 Table 116. Xiamen Boson Biotech Description and Business Overview
 Table 117. Xiamen Boson Biotech Toxoplasma Antigen Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Xiamen Boson Biotech Toxoplasma Antigen Test Product
 Table 119. Xiamen Boson Biotech Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Toxoplasma Antigen Test Distributors List
 Table 123. Toxoplasma Antigen Test Customers List
 Table 124. Toxoplasma Antigen Test Market Trends
 Table 125. Toxoplasma Antigen Test Market Drivers
 Table 126. Toxoplasma Antigen Test Market Challenges
 Table 127. Toxoplasma Antigen Test Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Toxoplasma Antigen Test
 Figure 2. Global Toxoplasma Antigen Test Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Toxoplasma Antigen Test Market Share by Type: 2024 & 2031
 Figure 4. Feces Product Picture
 Figure 5. Blood Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Toxoplasma Antigen Test Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Toxoplasma Antigen Test Market Share by Application: 2024 & 2031
 Figure 9. Mankind
 Figure 10. Animal
 Figure 11. Global Toxoplasma Antigen Test Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Toxoplasma Antigen Test Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Toxoplasma Antigen Test Sales (2020-2031) & (K Units)
 Figure 14. Global Toxoplasma Antigen Test Average Price (US$/Unit) & (2020-2031)
 Figure 15. Toxoplasma Antigen Test Report Years Considered
 Figure 16. Toxoplasma Antigen Test Sales Share by Manufacturers in 2024
 Figure 17. Global Toxoplasma Antigen Test Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Toxoplasma Antigen Test Players: Market Share by Revenue in Toxoplasma Antigen Test in 2024
 Figure 19. Toxoplasma Antigen Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Toxoplasma Antigen Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Toxoplasma Antigen Test Sales Market Share by Country (2020-2031)
 Figure 22. North America Toxoplasma Antigen Test Revenue Market Share by Country (2020-2031)
 Figure 23. United States Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Toxoplasma Antigen Test Sales Market Share by Country (2020-2031)
 Figure 26. Europe Toxoplasma Antigen Test Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Toxoplasma Antigen Test Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Toxoplasma Antigen Test Revenue Market Share by Region (2020-2031)
 Figure 34. China Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Toxoplasma Antigen Test Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Toxoplasma Antigen Test Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Toxoplasma Antigen Test Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Toxoplasma Antigen Test Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Toxoplasma Antigen Test Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Toxoplasma Antigen Test by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Toxoplasma Antigen Test by Type (2020-2031)
 Figure 53. Global Toxoplasma Antigen Test Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Toxoplasma Antigen Test by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Toxoplasma Antigen Test by Application (2020-2031)
 Figure 56. Global Toxoplasma Antigen Test Price (US$/Unit) by Application (2020-2031)
 Figure 57. Toxoplasma Antigen Test Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD